CI shareholders will receive $32.00 in cash per share, representing a 33% premium over the last closing price prior to the announcement of the arrangement and a 58% premium over the 60-day ...
Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback